Filing Details

Accession Number:
0001225208-20-003954
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-02 20:46:46
Reporting Period:
2020-02-27
Accepted Time:
2020-03-02 20:46:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1739940 Cigna Corp CI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1480601 G Matthew Manders 900 Cottage Grove Road
Bloomfield CT 06002
President, Strategy & Solution No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.01 Par Value Disposition 2020-02-27 548 $185.76 46,018 No 4 F Direct
Common Stock, $.01 Par Value Acquisiton 2020-02-28 6,305 $0.00 52,323 No 4 A Direct
Common Stock, $.01 Par Value Disposition 2020-02-28 2,336 $179.41 49,987 No 4 F Direct
Common Stock, $.01 Par Value Disposition 2020-03-02 3,969 $182.85 46,018 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 A Direct
No 4 F Direct
No 4 S Direct
Footnotes
  1. Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
  2. The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2017-2019 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
  3. Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
  4. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018.